Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Faisal Khurshid's Stock Ratings
Leerink Partners Analyst
Faisal Khurshid is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Overall Average Return
1.42%
Smart Score
Overall Average Return Percentile
46th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/14/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.90 | 10.8% | Faisal Khurshid43% | $3 → $1 | Maintains | Market Perform | Get Alert |
| 04/08/2025 | SYRE | Buy Now | Spyre Therapeutics | $14.66 | 206.96% | Faisal Khurshid43% | → $45 | Initiates | → Outperform | Get Alert |
| 03/17/2025 | NRIX | Buy Now | Nurix Therapeutics | $11.16 | 43.37% | Faisal Khurshid43% | → $16 | Initiates | → Market Perform | Get Alert |
| 03/17/2025 | STTK | Buy Now | Shattuck Labs | $1.07 | 273.83% | Faisal Khurshid43% | → $4 | Initiates | → Outperform | Get Alert |
| 03/03/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 21% | Faisal Khurshid43% | $33 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/18/2025 | ATYR | Buy Now | aTyr Pharma | $3.40 | 370.59% | Faisal Khurshid43% | → $16 | Initiates | → Outperform | Get Alert |
| 12/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 73.66% | Faisal Khurshid43% | $60 → $60 | Maintains | Outperform | Get Alert |
| 12/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $70.69 | 13.17% | Faisal Khurshid43% | → $80 | Initiates | → Outperform | Get Alert |
| 11/04/2024 | ZURA | Buy Now | Zura Bio | $1.47 | 920.41% | Faisal Khurshid43% | → $15 | Initiates | → Outperform | Get Alert |
| 09/09/2024 | TRVI | Buy Now | Trevi Therapeutics | $6.90 | 1.45% | Faisal Khurshid43% | → $7 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | PRTC | Buy Now | PureTech Health | $17.66 | 154.81% | Faisal Khurshid43% | → $45 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 1896.49% | Faisal Khurshid43% | → $33 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.90 | 454.02% | Faisal Khurshid43% | → $5 | Initiates | → Market Perform | Get Alert |
| 09/09/2024 | GLPG | Buy Now | Galapagos | $26.78 | -10.38% | Faisal Khurshid43% | → $24 | Initiates | → Market Perform | Get Alert |
| 09/09/2024 | GERN | Buy Now | Geron | $1.40 | 400% | Faisal Khurshid43% | → $7 | Initiates | → Outperform | Get Alert |
| 09/09/2024 | MNKD | Buy Now | MannKind | $4.90 | 63.27% | Faisal Khurshid43% | → $8 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 73.66% | Faisal Khurshid43% | → $60 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | IMUX | Buy Now | Immunic | $1.15 | 334.78% | Faisal Khurshid43% | → $5 | Assumes | → Outperform | Get Alert |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Faisal Khurshid43% | $17 → $21 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/21/2023 | RAIN | Buy Now | Rain Oncology | $4.56 | 141.23% | Faisal Khurshid43% | → $11 | Initiates | → Outperform | Get Alert |
